Silica-Coated Nanodiamonds for Imaging and Delivery of Therapeutic Agents
The NCI Radiation Oncology Branch and the NHLBI Laboratory of Single Molecule Biophysics seek parties to co-develop fluorescent nanodiamonds for use as in vivo and in vitro optical tracking probes toward commercialization.
NCI and NHLBI investigators invented a robust and easily implemented method of synthesizing silica-coated nanodiamonds for imaging and therapeutic applications. A patent estate covering these methods is offered for licensing to commercial entities. The method generally includes coating nanodiamonds with a silica precursor, e.g, tetraethylorthosilicate (TEOS), inside liposomes. The liposomes are then removed to yield a final product that is stable, monodisperse, and easy to functionalize.
- Imaging
- Drug delivery
- Small size
- Physiologically inert carrier
- Monodisperse
- Stable in aqueous solution
- Readily functionalized
- Biological activity is determined more efficiently than chemical analysis
- High Specificity and selectivity